List of Excipients in API moxifloxacin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing moxifloxacin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | MOXEZA | moxifloxacin hydrochloride | 0065-0006 | BORIC ACID | |
| Alcon Laboratories Inc | MOXEZA | moxifloxacin hydrochloride | 0065-0006 | HYDROCHLORIC ACID | |
| Alcon Laboratories Inc | MOXEZA | moxifloxacin hydrochloride | 0065-0006 | SODIUM CHLORIDE | |
| Alcon Laboratories Inc | MOXEZA | moxifloxacin hydrochloride | 0065-0006 | SODIUM HYDROXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing moxifloxacin hydrochloride
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 | CELLULOSE, MICROCRYSTALLINE |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 | CROSCARMELLOSE SODIUM |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 | FERRIC OXIDE RED |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 | HYPROMELLOSE 2910 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for moxifloxacin hydrochloride
Excipient focus: ANHYDROUS LACTOSE
moxifloxacin hydrochloride drug variants containing ANHYDROUS LACTOSE
moxifloxacin hydrochloride drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
moxifloxacin hydrochloride drug variants containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing BORIC ACID
Excipient focus: CELLULOSE, MICROCRYSTALLINE
moxifloxacin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
moxifloxacin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77491
moxifloxacin hydrochloride drug variants containing CI 77491
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-4058 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-4100 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing CI 77491
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77891
moxifloxacin hydrochloride drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-4058 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-4100 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
moxifloxacin hydrochloride drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | moxifloxacin hydrochloride | 51991-943 |
| Golden State Medical Supply Inc | moxifloxacin hydrochloride | 60429-893 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
moxifloxacin hydrochloride drug variants containing CROSCARMELLOSE SODIUM
moxifloxacin hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
moxifloxacin hydrochloride drug variants containing FERRIC OXIDE RED
moxifloxacin hydrochloride drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
moxifloxacin hydrochloride drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | moxifloxacin hydrochloride | 40032-034 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
moxifloxacin hydrochloride drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE 2910
moxifloxacin hydrochloride drug variants containing HYPROMELLOSE 2910
moxifloxacin hydrochloride drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
moxifloxacin hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | moxifloxacin hydrochloride | 40032-034 |
| Sunshine Lake Pharma Co Ltd | moxifloxacin hydrochloride | 48792-7823 |
| Physicians Total Care Inc | moxifloxacin hydrochloride | 54868-4367 |
| RedPharm Drug Inc | moxifloxacin hydrochloride | 67296-0154 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
moxifloxacin hydrochloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | moxifloxacin hydrochloride | 40032-034 |
| Physicians Total Care Inc | moxifloxacin hydrochloride | 54868-4367 |
| RedPharm Drug Inc | moxifloxacin hydrochloride | 67296-0154 |
| RedPharm Drug Inc | moxifloxacin hydrochloride | 67296-1299 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
moxifloxacin hydrochloride drug variants containing MAGNESIUM STEARATE
moxifloxacin hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
moxifloxacin hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sunshine Lake Pharma Co Ltd | moxifloxacin hydrochloride | 48792-7823 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-90
moxifloxacin hydrochloride drug variants containing PEG-90
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-7665 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing PEG-90
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
moxifloxacin hydrochloride drug variants containing POLYETHYLENE GLYCOL
moxifloxacin hydrochloride drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
moxifloxacin hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
moxifloxacin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
moxifloxacin hydrochloride drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | moxifloxacin hydrochloride | 0904-7407 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-6595 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-6609 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-7244 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
moxifloxacin hydrochloride drug variants containing POLYVINYL ALCOHOL
moxifloxacin hydrochloride drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
moxifloxacin hydrochloride drug variants containing POVIDONE K30
moxifloxacin hydrochloride drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
moxifloxacin hydrochloride drug variants containing SILICON DIOXIDE
moxifloxacin hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
moxifloxacin hydrochloride drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | moxifloxacin hydrochloride | 63323-850 |
| Hp Halden Pharma AS | moxifloxacin hydrochloride | 66298-8507 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
moxifloxacin hydrochloride drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
moxifloxacin hydrochloride drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
moxifloxacin hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | moxifloxacin hydrochloride | 0904-7407 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-6595 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-6609 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-7244 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM SULFATE
moxifloxacin hydrochloride drug variants containing SODIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | moxifloxacin hydrochloride | 63323-850 |
| Hp Halden Pharma AS | moxifloxacin hydrochloride | 66298-8507 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing SODIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
moxifloxacin hydrochloride drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
moxifloxacin hydrochloride drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | moxifloxacin hydrochloride | 13668-201 |
| Breckenridge Pharmaceutical Inc | moxifloxacin hydrochloride | 51991-943 |
| Golden State Medical Supply Inc | moxifloxacin hydrochloride | 60429-893 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
moxifloxacin hydrochloride drug variants containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | moxifloxacin hydrochloride | 63323-850 |
| Hp Halden Pharma AS | moxifloxacin hydrochloride | 66298-8507 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
moxifloxacin hydrochloride drug variants containing TALC
moxifloxacin hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
moxifloxacin hydrochloride drug variants containing TITANIUM DIOXIDE
moxifloxacin hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
Excipient focus: TYLOXAPOL
moxifloxacin hydrochloride drug variants containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing TYLOXAPOL
Excipient focus: VP/VA COPOLYMER
moxifloxacin hydrochloride drug variants containing VP/VA COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-4058 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-4100 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing VP/VA COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
moxifloxacin hydrochloride drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| Upsher-Smith Laboratories LLC | moxifloxacin hydrochloride | 0832-1410 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing WATER
Excipient focus: XANTHAN GUM
moxifloxacin hydrochloride drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing XANTHAN GUM
Excipient focus: ZEA MAYS
moxifloxacin hydrochloride drug variants containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-4058 |
| A-S Medication Solutions | moxifloxacin hydrochloride | 50090-4100 |
| >Company | >Ingredient | >NDC |
moxifloxacin hydrochloride drug variants not containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | moxifloxacin hydrochloride | 0065-0006 |
| Novartis Pharmaceuticals Corporation | moxifloxacin hydrochloride | 0078-0939 |
| Teva Pharmaceuticals USA Inc | moxifloxacin hydrochloride | 0093-7387 |
| Sandoz Inc | moxifloxacin hydrochloride | 0781-7135 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
